Riverview Trust Co Invests $26,000 in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Riverview Trust Co purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 1,373 shares of the medical instruments supplier’s stock, valued at approximately $26,000.

A number of other institutional investors have also recently made changes to their positions in the business. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA in the third quarter valued at approximately $27,000. Kennebec Savings Bank acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $35,000. MassMutual Private Wealth & Trust FSB increased its holdings in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. increased its stake in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares during the last quarter. Finally, Van ECK Associates Corp acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Down 3.5 %

XRAY opened at $16.55 on Friday. The stock has a market cap of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The stock’s fifty day simple moving average is $18.83 and its 200 day simple moving average is $21.50. DENTSPLY SIRONA Inc. has a 1-year low of $16.21 and a 1-year high of $34.91. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.87%. DENTSPLY SIRONA’s dividend payout ratio is -30.92%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Morgan Stanley lowered their target price on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Robert W. Baird lowered their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Wells Fargo & Company lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Eleven analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.